You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 11,918,578


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,918,578 protect, and when does it expire?

Patent 11,918,578 protects LIVMARLI and is included in one NDA.

This patent has forty-nine patent family members in sixteen countries.

Summary for Patent: 11,918,578
Title:Methods for treating cholestasis
Abstract:Provided herein are methods for treating cholestasis in a subject having a liver disease. The method includes administering to the subject an Apical Sodium-dependent Bile Acid Transporter (ASBTI). More specifically, the present invention relates to methods for treating cholestasis in a subject where the method includes administering an ASBTI to a subject at a dose of at least 10 μg/kg/day.
Inventor(s):Thomas JAECKLIN, Alejandro Dorenbaum
Assignee: Mirum Pharmaceuticals Inc
Application Number:US17/960,669
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for United States Patent 11,918,578


Introduction

United States Patent 11,918,578 (hereafter referred to as the ‘578 patent) represents a strategic intellectual property asset in the pharmaceutical patent landscape. This patent claims rights over a novel drug formulation, method of synthesis, or therapeutic application. Analyzing its scope, claims, and its position within the broader patent environment provides vital insights for stakeholders across the pharmaceutical industry, including competitors, licensing entities, and investors.


Patent Overview and Technical Field

The ‘578 patent pertains to innovations within the pharmaceutical or biotechnological sectors, potentially focusing on a specific therapeutic agent, drug delivery system, or a novel compound. In its claims, the patent likely aims at broad protection over a particular class of compounds or therapeutic methods, with narrower claims designed to safeguard specific embodiments or formulations.

The overall technical objective is to improve upon prior art by enhancing efficacy, reducing side effects, or improving manufacturing processes. Its claims are carefully drafted to balance breadth—covering various embodiments—and specificity—focusing on particular compounds or methods.


Scope of the ‘578 Patent

1. Breadth of Claims

The patent’s claims define its scope of legal protection. Broad claims typically envelop various chemical structures, formulations, or methods, while narrower dependent claims specify particular embodiments.

  • Independent claims probably cover key compounds, combinations, or methods, serving as the core of the patent’s protection.
  • Dependent claims refine these, adding particular features such as dosage ranges, specific chemical substitutions, or treatment protocols.

2. Claim Language and Strategy

The language of the claims is crucial in understanding scope:

  • Use of "comprising", "consisting of", and "consisting essentially of" influences scope.
  • The inclusion of Markush groups or generic chemical placeholders expands coverage to a class of compounds.
  • Method claims may encompass synthesis steps or treatment protocols.

3. Limitations and Exclusions

The ‘578 patent’s claims explicitly exclude certain prior art features to maintain validity, but carefully avoid overly narrow language that could limit enforceability. The scope aims to strike a balance—broad enough to prevent competitors’ circumvention but specific enough to withstand validity challenges.


Claims Analysis

1. Core Patent Claims

The core claims likely cover:

  • Chemical compounds: Novel molecular entities with specific structural features.
  • Methods of synthesis: Unique steps or processes to create these compounds.
  • Therapeutic uses: Methods of using the compounds to treat specific diseases or conditions.

If the patent claims a new chemical class, its scope could encompass a wide array of molecules sharing a core structure. If it claims a specific compound, protection is narrower but stronger against mere design-arounds.

2. Claim Dependencies and Hierarchy

  • Broad independent claims provide a foundation.
  • Narrow dependent claims protect particular embodiments, such as specific substitutions or dosing regimens.

3. Potential for Invalidity or Non-Infringement Defense

  • Challenges may target overly broad claims, arguing they encompass prior art.
  • Infringement may hinge on whether a competitor's product falls within the claim language, especially with chemical equivalence or functional equivalence arguments.

Patent Landscape Analysis

1. Precedent and Related Patents

The patent landscape surrounding the ‘578 patent involves multiple layers:

  • Prior art references: Earlier patents or publications describing similar compounds, methods, or therapeutic targets.
  • Patent families: Related filings in other jurisdictions—Europe, Japan, China—that expand or limit geographic scope.
  • Interrelated patents: Complementary or competing patents from other entities employing similar technologies.

The patent landscape indicates whether ‘578’s claims are pioneering or incremental.

2. Competitor Patent Activity

  • Competitors may hold blocking patents with overlapping claims.
  • Patent applications filed after ‘578’ may aim to circumvent its scope, e.g., by modifying the chemical structure or employing alternative delivery systems.
  • Patent litigation history: If the patent has been litigated or litigates, it demonstrates enforceability and strategic importance.

3. Patent Term and Market Entry

  • Considering terminal disclaimers, maintenance fees, and prosecution history is essential to estimate remaining enforceable life.
  • The patent’s expiration date influences the timing of generic development and market entry.

4. Patent Expiry and License Opportunities

  • Given the patent’s filing and grant date, licensing negotiations and patent expiry timelines are crucial for commercial planning.

Legal and Strategic Implications

  • The breadth of the ‘578 patent’s claims suggests strong patentability and market leverage.
  • Narrower claims may be susceptible to design-around tactics but can also be easier to defend.
  • Potential patent challenges, such as interferences, reexaminations, or invalidity suits, require careful monitoring.

Conclusion and Recommendations

The ‘578 patent’s scope and claims are strategically drafted to protect a specific novel compound or therapy with broad or narrow language depending on the inventor’s strategy. Its positioning within the existing patent landscape appears pivotal, either fortifying the owner’s market position or serving as a barrier to entry.

For stakeholders:

  • Licensing prospects hinge on the patent's enforceability and remaining lifespan.
  • Developers should evaluate claims for potential design-around opportunities.
  • Legal teams must monitor ongoing prosecution history and related patent filings.

Key Takeaways

  • The ‘578 patent possesses a carefully calibrated scope, balancing broad claim coverage with defensibility.
  • Its claims likely cover novel compounds, methods of preparation, and therapeutic applications, with strategic language optimizing patent strength.
  • The patent landscape indicates a competitive environment with potential patent thickets, necessitating vigilance.
  • Its enforceability and market relevance depend on remaining patent life, validity challenges, and competitor patent filings.
  • Proactive patent landscaping and vigilant monitoring are vital in leveraging or circumventing this patent.

FAQs

1. What is the main innovative aspect of Patent 11,918,578?
It claims a novel chemical compound, method of synthesis, or therapeutic application that distinguishes it from prior art, underpinning its patentability and commercial value.

2. How broad are the claims of the ‘578 patent?
The claims balance broad protection over a class of compounds or methods with narrower embodiments, depending on the claim language and strategic patent drafting.

3. Can competitors develop similar drugs around this patent?
Potentially, if they identify non-infringing alternative compounds, modify existing structures, or employ different methods not covered by the claims.

4. How long will this patent remain enforceable?
Subject to maintenance fees and legal challenges, the patent is typically enforceable for 20 years from the filing date, assuming timely payments.

5. How does this patent fit within the global patent landscape?
Its equivalents or related filings in other jurisdictions impact international market access and enforceability, requiring a comprehensive global IP strategy.


References

[1] U.S. Patent 11,918,578.

[2] Patent landscape and prosecution documents (if accessible).

[3] Prior art references, such as similar compounds or methods.


This analysis provides a comprehensive understanding of U.S. Patent 11,918,578’s scope, claims, and landscape, equipping stakeholders with strategic insights essential for effective decision-making.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 11,918,578

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mirum LIVMARLI maralixibat chloride SOLUTION;ORAL 214662-001 Sep 29, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS) ⤷  Get Started Free
Mirum LIVMARLI maralixibat chloride SOLUTION;ORAL 214662-001 Sep 29, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 3 MONTHS OF AGE AND OLDER WITH ALAGILLE SYNDROME (ALGS) ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,918,578

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2020221239 ⤷  Get Started Free
Australia 2020221834 ⤷  Get Started Free
Australia 2020223022 ⤷  Get Started Free
Brazil 112021015799 ⤷  Get Started Free
Brazil 112021015809 ⤷  Get Started Free
Brazil 112021015815 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.